CN1057230C - Traditional Chinese medicine capsule for treating thrombophlebitis - Google Patents

Traditional Chinese medicine capsule for treating thrombophlebitis Download PDF

Info

Publication number
CN1057230C
CN1057230C CN98119889A CN98119889A CN1057230C CN 1057230 C CN1057230 C CN 1057230C CN 98119889 A CN98119889 A CN 98119889A CN 98119889 A CN98119889 A CN 98119889A CN 1057230 C CN1057230 C CN 1057230C
Authority
CN
China
Prior art keywords
radix
rhizoma
rhizoma atractylodis
semen
formica fusca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98119889A
Other languages
Chinese (zh)
Other versions
CN1212885A (en
Inventor
李正武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98119889A priority Critical patent/CN1057230C/en
Publication of CN1212885A publication Critical patent/CN1212885A/en
Application granted granted Critical
Publication of CN1057230C publication Critical patent/CN1057230C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a traditional Chinese medicine capsule for treating thrombophlebitis. The present invention adopts traditional Chinese medicines, such as ants, angelica, spatholobus stems, achyranthes roots, phellodendron bark, astragalus roots, white atractylodes rhizomes, red sage roots, etc. as raw materials, the traditional Chinese medicines are manufactured into medicinal powder through the technological processes of pulverization, immersion, decoction, filtration, concentration, ethanol extraction, mixing, porphyrization, etc. according to the properties of the traditional Chinese medicines, and then, the medicinal powder is encapsulated. The present invention has unique prescription and high cure rate.

Description

The Chinese medicinal capsule of treatment thrombophlebitis
The present invention relates to a kind of Chinese medicine preparation for the treatment of peripheral vascular disease.
Thrombophlebitis is that the vessel wall inflammation secondary thrombus forms.The formation reason of thrombosis is also unclear fully at present, it is generally acknowledged wall of vein damage, blood flow is slow and blood coagulation to increase be the key factor that forms.The western medical treatment thrombophlebitis generally adopts operative therapy: vein ligatures, vein excises and thrombosis is extractd.According to clinical practice, the state of an illness still can recur after many patients performed the operation, and the repeatedly operation that has is not cured yet.Operative therapy not only has certain misery to the patient, and cure rate is lower.The Western medicine oral dicoumarols of injecting heparin commonly used etc., price is more expensive, and side effect is arranged.For the traditional Chinese medical science, Chinese medicine preparation was many in the past dehumidifies to controlling to invigorate blood circulation, and has ignored the treatment of detoxifcation, removing heat from blood, and therefore used pharmaceutical treatment effect is relatively poor.
The object of the present invention is to provide a kind of pure Chinese medicine capsule for the treatment of thrombophlebitis, not only have the very significant advantage of therapeutic effect, and taking convenience.
Solution of the present invention is based on the treatment theory of motherland's medical science to peripheral angiopathy, in conjunction with clinical practice, from motherland's Chinese medicine treasure-house, filter out invigorate blood circulation, removing heat from blood, the detoxifcation, the dehumidifying, promoting the circulation of blood is enriched blood, the pure Chinese medicine of Shujin, collateral dredging by the theory of Chinese medical science prescription, skims the cream off milk, make it have blood vessel dilating, thrombus, accelerate blood circulation, change local blood supply state, improve body immunity, setting upright gets rid of evils is fully recovered thrombophlebitis.
The proportioning raw materials of Chinese medicinal capsule of the present invention (with weight portion):
Formica fusca 3-10 Radix Glycyrrhizae 1-10 Semen Persicae 3-9 Rhizoma Curcumae 2-9
Radix Salviae Miltiorrhizae 1-10 Radix Clematidis 1-6 Radix Achyranthis Bidentatae 1-12 Radix Angelicae Sinensis 3-15
Rhizoma Corydalis 2-9 Radix Astragali 1-15 Cortex Phellodendri 1-6 Rhizoma Alismatis 2-10
Herba Artemisiae Scopariae 5-30 Semen Phaseoli 1-6 Radix Stephaniae Tetrandrae 2-9 Herba Eupatorii 6-10
Rhizoma Atractylodis Macrocephalae 1-15 Caulis Spatholobi 5-30 Rhizoma Atractylodis 3-10 Radix Paeoniae Rubra 5-15
Caulis Akebiae 1-5 Flos Lonicerae 1-20 Fructus Amomi Rotundus 1-9
Preferred weight (part) ratio range of preparation Chinese medicinal capsule of the present invention is:
Formica fusca 5-8 Radix Glycyrrhizae 3-8 Semen Persicae 5-7 Rhizoma Curcumae 5-7
Radix Salviae Miltiorrhizae 3-8 Radix Clematidis 3-5 Radix Achyranthis Bidentatae 3-10 Radix Angelicae Sinensis 5-10
Rhizoma Corydalis 5-7 Radix Astragali 3-10 Cortex Phellodendri 3-5 Rhizoma Alismatis 4-8
Herba Artemisiae Scopariae 8-20 Semen Phaseoli 3-5 Radix Stephaniae Tetrandrae 4-7 Herba Eupatorii 7-9
Rhizoma Atractylodis Macrocephalae 4-12 Caulis Spatholobi 7-25 Rhizoma Atractylodis 5-8 Radix Paeoniae Rubra 8-12
Caulis Akebiae 2-4 Flos Lonicerae 4-15 Bai Fructus Amomi Rotundus 1-9
The optimum weight of Chinese medicinal capsule of the present invention (part) ratio range is:
Formica fusca 6 Radix Glycyrrhizaes 5 Semen Persicaes 6 Rhizoma Curcumae 5
Radix Salviae Miltiorrhizae 5 Radix Clematidis 3 Radix Achyranthis Bidentataes 6 Radix Angelicae Sinensis 8
Rhizoma Corydalis 5 Radixs Astragali 8 Cortex Phellodendris 4 Rhizoma Alismatis 6
Herba Artemisiae Scopariae 15 Semen Phaseolis 4 Radixs Stephaniae Tetrandrae 6 Herba Eupatoriis 8
The Rhizoma Atractylodis Macrocephalae 8 Caulis Spatholobis 15 Rhizoma Atractylodis 7 Radix Paeoniae Rubra 10
Caulis Akebiae 3 Flos Loniceraes 10 Fructus Amomi Rotunduss 8
The production method that above-mentioned each component is made Chinese medicinal capsule of the present invention is:
1, Formica fusca is worn into coarse powder, the little stir-fry of all the other medicines, fragmentation;
2, the total amount input is carried jar, and the octuple water logging that adds weight was steeped 6 hours, decocted filtration in 40 minutes, adds six times of water gagings again and decocts 30 minutes after-filtration, merges filtrate twice;
3, filtrate concentrates (contracting to 1ml by the 1g crude drug);
4, adding ethanol makes the alcohol amount of containing reach 60-70% to stir evenly, left standstill 24 hours, cross the leaching supernatant, get ethanol (reaching relative density more than 1.10);
5, get above-mentioned concentrated solution and add an amount of food starch, dry in the shade, porphyrize, cross 120 mesh sieves and make powder;
6, incapsulate with the 0.5g/ grain.
The instructions of taking of Chinese medicinal capsule of the present invention: three times on the one, each 1-3 grain, one hour ante cibum (empty clothes), boiled water send down.
Chinese medicinal capsule of the present invention shows that through clinical use result following advantage is arranged:
1, because described medical material: Formica fusca has antiinflammatory, the analgesic significantly acts on, help to eliminate immune complex in the body, can control the inferior limb stain infections, but Radix Glycyrrhizae heat-clearing and toxic substances removing, relieving spasm to stop pain, but Semen Persicae activating blood and removing stasis, promoting the circulation of QI to relieve pain, but Radix Salviae Miltiorrhizae activating blood and removing stasis, removing heat from blood disappears bitterly, nourishing blood to tranquillize the mind, but Radix Clematidis wind-damp dispelling, the meridian dredging, stopping numbness pain, but Radix Achyranthis Bidentatae activating blood and removing stasis, inducing diuresis for treating stranguria syndrome, conducting blood to flow downwards, but the Radix Angelicae Sinensis blood circulation promoting and enriching, Rhizoma Corydalis can be invigorated blood circulation, circulation of qi promoting relieves the pain, but the Caulis Spatholobi promoting the circulation of blood is enriched blood, relaxing muscles and tendons and activating QI and blood in the collateral, but Radix Astragali tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, holder skin ulcer granulation promoting, inducing diuresis to remove edema, but Cortex Phellodendri heat-clearing and toxic substances removing dampness, but Rhizoma Alismatis promoting diuresis to eliminate damp pathogen, expel the heat-evil, but the Flos Lonicerae heat-clearing and toxic substances removing, but Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis, it is dirty that but the Herba Eupatorii removing dampness is warded off, but Semen Phaseoli eliminating dampness by diuresis heat clearing away, removing toxic substances and promoting pus discharge, the Radix Stephaniae Tetrandrae wind-damp dispelling, inducing diuresis to remove edema, but Rhizoma Atractylodis Macrocephalae QI invigorating, spleen invigorating, dampness, the Fructus Amomi Rotundus removing dampness by means of aromatics, therefore, comprehensively respectively the distinguish the flavor of effect of Chinese medicine of the present invention, make prescription not only have the effect of the dehumidifying of invigorating blood circulation, and detoxifcation is arranged, removing heat from blood is fruit.Phlebitis patient takes the present invention's Chinese medicine preparation, and therapeutic effect is very remarkable.
2, because the present invention be a pure Chinese medicinal preparation, each component meets pharmaceutical control law regulation, thus nontoxic, harmless to human body, have no side effect.
3,, and meet national drug health regulation because the present invention is the Chinese medicinal capsule taking convenience.
The present invention has very significant curative effect through the clinical observation of 102 routine systems to thrombophlebitis, can be found out by following table: to the deep phlebitis cure rate more than 86%, and comprehensive cure rate 95.1%.
Thrombophlebitis therapeutic effect statistical table
The course of treatment Clinical manifestation (number) Therapeutic effect (%)
Superficial phlebitis Deep phlebitis
One course of treatment Effectively 80 22 100%
Cure 31 4 34.3%
Two courses of treatment Cure 34 9 65.7%
Three courses of treatment Cure little vestige that has 13 6 3 82.6%
Therapeutic effect Effectively 100% 100% 100%
Cure 97.5% 86.3% 95.1%
Embodiment:
Take by weighing raw material (kilogram) by following proportioning:
Formica fusca 8 Radix Glycyrrhizaes 8 Semen Persicaes 7 Rhizoma Curcumae 7
Radix Salviae Miltiorrhizae 8 Radix Clematidis 5 Radix Achyranthis Bidentataes 10 Radix Angelicae Sinensis 10
Rhizoma Corydalis 7 Radixs Astragali 10 Cortex Phellodendris 5 Rhizoma Alismatis 8
Herba Artemisiae Scopariae 20 Semen Phaseolis 5 Radixs Stephaniae Tetrandrae 7 Herba Eupatoriis 9
The Rhizoma Atractylodis Macrocephalae 12 Caulis Spatholobis 20 Rhizoma Atractylodis 8 Radix Paeoniae Rubra 12
Caulis Akebiae 4 Flos Loniceraes 15 Fructus Amomi Rotunduss 9
Production method is as follows:
(1) Formica fusca is worn into coarse powder, the little stir-fry of all the other medicines, fragmentation; (2) the total amount input is carried jar, and the octuple water logging that adds weight was steeped 6 hours, decocted filtration in 40 minutes, adds six times of water gagings again and decocts 30 minutes after-filtration, merges filtrate twice; (3) filtrate concentrates (contracting to 1ml by the 1g crude drug); (4) adding ethanol makes the alcohol amount of containing reach 60-70% to stir evenly, left standstill 24 hours, cross the leaching supernatant, get ethanol and reach relative density more than 110; (5) get above-mentioned concentrated solution and add an amount of food starch, dry in the shade, porphyrize, cross 120 mesh sieves and make powder; (6) incapsulate with the 0.5g/ grain.

Claims (4)

1, a kind of Chinese medicinal capsule for the treatment of thrombophlebitis is characterized in that the weight proportion of each raw material is:
Formica fusca 3-10 Radix Glycyrrhizae 1-10 Semen Persicae 39 Rhizoma Curcumae 2-9
Radix Salviae Miltiorrhizae 1-10 Radix Clematidis 1-6 Radix Achyranthis Bidentatae 1-12 Radix Angelicae Sinensis 3-15
Rhizoma Corydalis 2-9 Radix Astragali 1-15 Cortex Phellodendri 1-6 Rhizoma Alismatis 2-10
Herba Artemisiae Scopariae 5-30 Semen Phaseoli 1-6 Radix Stephaniae Tetrandrae 2-9 Herba Eupatorii 6-10
Rhizoma Atractylodis Macrocephalae 1-15 Caulis Spatholobi 5-30 Rhizoma Atractylodis 3-10 Radix Paeoniae Rubra 5-15
Caulis Akebiae 1-5 Flos Lonicerae 1-20 Fructus Amomi Rotundus 1-9 wears into coarse powder with Formica fusca, the little stir-fry of all the other medicines, fragmentation; The total amount input is carried jar, and the octuple water logging that adds weight was steeped 6 hours, decocted filtration in 40 minutes, adds six times of water gagings again and decocts 30 minutes after-filtration, merges filtrate twice; It is concentrated to 1ml to contract by the 1g crude drug; Adding ethanol makes the alcohol amount of containing reach 60-70% to stir evenly, left standstill 24 hours, cross the leaching supernatant, get ethanol and reach relative density more than 110: get above-mentioned concentrated solution and add an amount of food starch, dry in the shade, porphyrize, cross 120 mesh sieves and make powder; Incapsulate with the 0.5g/ grain.
2, the Chinese medicinal capsule of treatment thrombophlebitis according to claim 1, wherein the weight proportion of each raw material is:
Formica fusca 5-8 Radix Glycyrrhizae 3-8 Semen Persicae 5-7 Rhizoma Curcumae 5-7
Radix Salviae Miltiorrhizae 3-8 CHENGLINGXIAN 3-5 Radix Achyranthis Bidentatae 3-10 Radix Angelicae Sinensis 5-10
Rhizoma Corydalis 5-7 Radix Astragali 3-10 Cortex Phellodendri 3-5 Rhizoma Alismatis 4-8
Herba Artemisiae Scopariae 8-20 Semen Phaseoli 3-5 Radix Stephaniae Tetrandrae 4-7 Herba Eupatorii 7-9
Rhizoma Atractylodis Macrocephalae 4-12 Caulis Spatholobi 7-25 Rhizoma Atractylodis 5-8 Radix Paeoniae Rubra 8-12
Caulis Akebiae 2-4 Flos Lonicerae 4-15 Fructus Amomi Rotundus 1-9
3, the Chinese medicinal capsule of treatment thrombophlebitis according to claim 1, wherein the weight proportion of each raw material is:
Formica fusca 6 Radix Glycyrrhizaes 5 Semen Persicaes 6 Rhizoma Curcumae 5
Radix Salviae Miltiorrhizae 5 Radix Clematidis 3 Radix Achyranthis Bidentataes 6 Radix Angelicae Sinensis 8
Rhizoma Corydalis 5 Radixs Astragali 8 Cortex Phellodendris 4 Rhizoma Alismatis 6
Herba Artemisiae Scopariae 15 Semen Phaseolis 4 Radixs Stephaniae Tetrandrae 6 Herba Eupatoriis 8
The Rhizoma Atractylodis Macrocephalae 8 Caulis Spatholobis 15 Rhizoma Atractylodis 7 Radix Paeoniae Rubra 10
Caulis Akebiae 3 Flos Loniceraes 10 Fructus Amomi Rotunduss 8
4, the manufacture method of the Chinese medicinal capsule of claim 1,2 or 3 described treatment thrombophlebitis is characterized in that technology step poly-ly is:
(1) prepares Chinese crude drug in Formica fusca 3-10, Radix Glycyrrhizae 1-10, Semen Persicae 3-9, Rhizoma Curcumae 2-9, Radix Salviae Miltiorrhizae 1-10, Radix Clematidis 1-6, Radix Achyranthis Bidentatae 1-12, Radix Angelicae Sinensis 3-15, Rhizoma Corydalis 2-9, Radix Astragali 1-15, Cortex Phellodendri 1-6, Rhizoma Alismatis 210, Herba Artemisiae Scopariae 5-30, Semen Phaseoli 1-6, Radix Stephaniae Tetrandrae 2-9, Herba Eupatorii 6-10, Rhizoma Atractylodis Macrocephalae 1-15, Caulis Spatholobi 5-30, Rhizoma Atractylodis 3-10, Radix Paeoniae Rubra 5-15, Caulis Akebiae 1-5, Flos Lonicerae 1-20, Fructus Amomi Rotundus 1-9 ratio;
(2) Formica fusca is worn into coarse powder, the little stir-fry of all the other medicines, fragmentation;
(3) the total amount input is carried jar, and the octuple water logging that adds weight was steeped 6 hours, decocted filtration in 40 minutes, adds six times of water gagings again and decocts 30 minutes after-filtration, merges filtrate twice;
(4) contract to 1ml by the 1g crude drug and concentrate;
(5) adding ethanol makes the alcohol amount of containing reach 60-70% to stir evenly, left standstill 24 hours, cross the leaching supernatant, get ethanol and reach relative density more than 110;
(6) get above-mentioned concentrated solution and add an amount of food starch, dry in the shade, porphyrize, cross 120 mesh sieves and make powder;
(7) incapsulate with the 0.5g/ grain.
CN98119889A 1998-09-28 1998-09-28 Traditional Chinese medicine capsule for treating thrombophlebitis Expired - Fee Related CN1057230C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98119889A CN1057230C (en) 1998-09-28 1998-09-28 Traditional Chinese medicine capsule for treating thrombophlebitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98119889A CN1057230C (en) 1998-09-28 1998-09-28 Traditional Chinese medicine capsule for treating thrombophlebitis

Publications (2)

Publication Number Publication Date
CN1212885A CN1212885A (en) 1999-04-07
CN1057230C true CN1057230C (en) 2000-10-11

Family

ID=5226502

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98119889A Expired - Fee Related CN1057230C (en) 1998-09-28 1998-09-28 Traditional Chinese medicine capsule for treating thrombophlebitis

Country Status (1)

Country Link
CN (1) CN1057230C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102008684B (en) * 2010-11-14 2012-06-06 王爱华 Traditional Chinese medicine composition for curing level-IV chemotherapeutic phlebitis
CN102727615A (en) * 2012-07-06 2012-10-17 王彬 Traditional Chinese medicine for treating deep venous thrombosis and method for preparing traditional Chinese medicine
CN104491694A (en) * 2014-12-03 2015-04-08 李强 Medicament for treating venous insufficiency and secondary diseases and complications of venous insufficiency
CN104873611B (en) * 2015-05-28 2018-02-16 赖祥林 A kind of medicine for treating erythromelalgia
CN105477596A (en) * 2015-12-16 2016-04-13 昝世永 Traditional Chinese medicinal composition for treating extremity superficial thrombophlebitis
CN105362551A (en) * 2015-12-28 2016-03-02 赵红 Traditional Chinese medicine treating phlebitis and preparation method for traditional Chinese medicine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1132081A (en) * 1995-03-25 1996-10-02 张桂勤 Medicine for treatment of strip scleroma of thrombus phlebitis
CN1183281A (en) * 1996-11-22 1998-06-03 凌沛学 Ointment contg. low-molecular heparin and its preparing method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1132081A (en) * 1995-03-25 1996-10-02 张桂勤 Medicine for treatment of strip scleroma of thrombus phlebitis
CN1183281A (en) * 1996-11-22 1998-06-03 凌沛学 Ointment contg. low-molecular heparin and its preparing method

Also Published As

Publication number Publication date
CN1212885A (en) 1999-04-07

Similar Documents

Publication Publication Date Title
CN1298346C (en) Dynamic medicine for channels and collaterals and blood vessel
CN1286490C (en) anti inflammation decoction for treating morbid leucorrhea, etc.
CN1171970A (en) Health-care wine with antisenility function
CN101028441A (en) Energy-supplemented liquid health-care medicinal liquor
CN1176814A (en) Oral liquor for preventing and curing cerebrovascular disease
CN1268355A (en) Yichanmanshenkang medicine for curing nephroses
CN1278446A (en) Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease
CN1824205A (en) Medicine for treating chronic prostatitis and its preparation method
CN1057230C (en) Traditional Chinese medicine capsule for treating thrombophlebitis
CN1074281C (en) Chinese medicine prepn
CN1061543C (en) Compound pill of trachitis
CN1242201A (en) Patent traditional Chinese medicine for treating psoriasis, and method for preparing same
CN1228063C (en) Medicine for treating liver disease
CN1053189A (en) The preparation method of " promoting blood circulation and restoring paralysis pills "
CN1077896A (en) Medicine for psoriasis and manufacture method
CN101642532A (en) Traditional Chinese medicine composition for treating apoplexy and preparation method thereof
CN1180821C (en) Medicine for treating cerebral thrombus and its prepn
CN1209142C (en) Rongshuan jiannaokang thrombolytic
CN1055220C (en) Chinese drug for treatment of hemiplegia
CN104225406A (en) Chinese medicine for treating lung abscess
CN1298724A (en) Medicine for treating immunodefiiciency disease
CN1296835A (en) Exterior applied liquid Chinese medicine for treating diarrhea
CN1244370C (en) Medicinal composition for curing skin disease
CN1342478A (en) Medical wine for treating rheumatism
CN1058181C (en) Health-care wine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee